A post-marketing surveillance study of Neutrolin, a novel catheter lock solution, in hemodialysis patients with tunneled central venous catheters (CVC)
Phase of Trial: Phase IV
Latest Information Update: 05 May 2016
At a glance
- Drugs Citrate/heparin/taurolidine (Primary)
- Indications Catheter infections
- Focus Adverse reactions
- 05 May 2016 According to a CorMedix media release, data (n=199) from this study were presented at the 1st Gulf Congress of Clinical Microbiology and Infectious Diseases.
- 01 Jun 2015 According to a CorMedix media release, data from this study was presented at the European Renal Association's 52nd European Dialysis and Transplant Association (ERA-EDTA) Congress.
- 30 Apr 2015 New trial record